News | Radiation Therapy | July 05, 2019

Aktina Medical Partners With Elekta for Global Distribution of Interlocking SRS Cones

Cones allow radiation therapy clinics to deliver stereotactic radiosurgery with existing general purpose radiotherapy equipment

Aktina Medical Partners With Elekta for Global Distribution of Interlocking SRS Cones

July 5, 2019 — Aktina Medical announced that Elekta Instrument AB, based in Sweden, will offer and distribute the Aktina line of patented SRS Cones globally for use in cancer treatments and other appropriate radiation therapies.

The use of calibrated cones in stereotactic radiosurgery has grown in recent years, particularly in clinics that do not have access to the most advanced special-purpose radiation treatment equipment. By using the Aktina SRS Cones, such clinics can deliver highly accurate SRS treatments using their existing general-purpose radiation treatment equipment.

Unlike previous solutions, the Aktina SRS Cone system features lead-based interlocking cones with stainless steel sleeves that have carved channels and grooves that match corresponding channels and grooves carved into the applicator. As each cone is inserted into the applicator, they depress (or don’t depress) specific switches, and confirm by their own insertion that they are the proper size cone for the programmed dosage. The control software, which has been integrated with the cones and applicator, compares the installed cone with the programmed plan and confirms they match before proceeding. In this way, automated treatment verification lets technicians benefit from fast, simple equipment setup while ensuring they deliver the correct dosage and treatment specified for the patients.

For more information: www.aktina.com, www.elekta.com

Related Content

IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and SCK CEN (Belgian Nuclear Research Center) announced a strategic R&D partnership to enable the production of Actinimum-225 (225Ac), a novel radioisotope which has significant potential in the treatment of cancer.
News | Radiation Oncology | September 17, 2021
September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, a
Evaluation of therapeutic efficacy of drug candidates in preclinical oncology with positron emission tomography (PET)

Getty Images

Feature | PET Imaging | September 14, 2021 | By Todd Sasser, Ph.D.
With a wealth of landmark studies in Breast, Cervical, Melanoma, Prostate, Colorectal, Oesophagus, Endocrine and Lung cancer, the ESMO Congress 2021 is a clear demonstration that oncology research has once again gathered momentum after being temporarily stopped in its tracks by the outbreak of the virus

Getty Images

News | Radiation Oncology | September 13, 2021
September 13, 2021 — At the opening press conference of the ...
Comment letters on the 2022 physician fee schedule and Radiation Oncology Model urge CMS to scale back extreme cuts that jeopardize access to life-saving cancer treatments

Getty Images

News | ASTRO | September 09, 2021
September 9, 2021 — The American Society for Radiation Oncology (AS...

Image of a STING protein, courtesy of UCLA Jonsson Comprehensive Cancer Center

News | PET Imaging | September 08, 2021
September 8, 2021 — A new study from scientists at the UCLA Jonsso...
An artificial intelligence (AI) program can spot signs of lung cancer on computed tomography (CT) scans a year before they can be diagnosed with existing methods, according to research presented at the European Respiratory Society International Congress.

Diagram showing details of the lung screening experiment. Image courtesy of the European Respiratory Society/Benoit Audelan

News | Artificial Intelligence | September 08, 2021
September 8, 2021 — An artificial intell...
At the recent 2021 AAPM Meeting in July, Sun Nuclear Corporation featured its comprehensive portfolio of independent, integrated quality management solutions for radiation therapy and diagnostic imaging.
News | Quality Assurance (QA) | September 02, 2021
September 2, 2021 — At the recent 2021 AAPM Meeting
Cedars-Sinai Cancer researchers have discovered that intestinal microorganisms help regulate anti-tumor immune responses to radiation treatments.

Getty Images

News | Radiation Therapy | September 01, 2021
September 1, 2021 — The study, published on Aug.